nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—OPRK1—alcohol dependence	0.348	0.446	CbGaD
Naltrexone—OPRD1—alcohol dependence	0.245	0.314	CbGaD
Naltrexone—OPRM1—alcohol dependence	0.188	0.24	CbGaD
Naltrexone—ABCB1—Citalopram—alcohol dependence	0.00272	1	CbGbCtD
Naltrexone—OPRM1—nerve—alcohol dependence	0.00214	0.108	CbGeAlD
Naltrexone—OPRD1—forebrain—alcohol dependence	0.0013	0.0658	CbGeAlD
Naltrexone—OPRK1—forebrain—alcohol dependence	0.00124	0.0631	CbGeAlD
Naltrexone—OPRM1—brainstem—alcohol dependence	0.000917	0.0465	CbGeAlD
Naltrexone—OPRM1—forebrain—alcohol dependence	0.000885	0.0449	CbGeAlD
Naltrexone—UGT1A1—digestive system—alcohol dependence	0.00079	0.0401	CbGeAlD
Naltrexone—UGT1A1—blood—alcohol dependence	0.000752	0.0382	CbGeAlD
Naltrexone—OPRD1—nervous system—alcohol dependence	0.000705	0.0357	CbGeAlD
Naltrexone—OPRD1—central nervous system—alcohol dependence	0.000678	0.0344	CbGeAlD
Naltrexone—OPRK1—nervous system—alcohol dependence	0.000675	0.0343	CbGeAlD
Naltrexone—UGT1A1—endocrine gland—alcohol dependence	0.000653	0.0331	CbGeAlD
Naltrexone—OPRK1—central nervous system—alcohol dependence	0.00065	0.033	CbGeAlD
Naltrexone—OPRK1—cerebellum—alcohol dependence	0.000636	0.0322	CbGeAlD
Naltrexone—Upset stomach—Citalopram—alcohol dependence	0.000599	0.00435	CcSEcCtD
Naltrexone—OPRM1—blood—alcohol dependence	0.000592	0.03	CbGeAlD
Naltrexone—UGT1A1—liver—alcohol dependence	0.000588	0.0299	CbGeAlD
Naltrexone—OPRM1—midbrain—alcohol dependence	0.000585	0.0297	CbGeAlD
Naltrexone—Abdominal cramps—Citalopram—alcohol dependence	0.000582	0.00422	CcSEcCtD
Naltrexone—Pharyngolaryngeal pain—Citalopram—alcohol dependence	0.000582	0.00422	CcSEcCtD
Naltrexone—Paranoia—Citalopram—alcohol dependence	0.000576	0.00418	CcSEcCtD
Naltrexone—Laryngeal pain—Citalopram—alcohol dependence	0.000576	0.00418	CcSEcCtD
Naltrexone—Hyperkinesia—Acamprosate—alcohol dependence	0.000571	0.00415	CcSEcCtD
Naltrexone—Mental disability—Acamprosate—alcohol dependence	0.000569	0.00413	CcSEcCtD
Naltrexone—Suicidal ideation—Citalopram—alcohol dependence	0.00056	0.00406	CcSEcCtD
Naltrexone—Lymphadenopathy—Acamprosate—alcohol dependence	0.000557	0.00404	CcSEcCtD
Naltrexone—Phlebitis—Acamprosate—alcohol dependence	0.000552	0.00401	CcSEcCtD
Naltrexone—Laryngitis—Citalopram—alcohol dependence	0.000545	0.00395	CcSEcCtD
Naltrexone—Butorphanol—OPRK1—alcohol dependence	0.00054	0.0667	CrCbGaD
Naltrexone—Methylnaltrexone—OPRK1—alcohol dependence	0.00054	0.0667	CrCbGaD
Naltrexone—OPRD1—brain—alcohol dependence	0.000539	0.0273	CbGeAlD
Naltrexone—Gastroenteritis—Acamprosate—alcohol dependence	0.000537	0.00389	CcSEcCtD
Naltrexone—OPRK1—brain—alcohol dependence	0.000516	0.0262	CbGeAlD
Naltrexone—OPRM1—endocrine gland—alcohol dependence	0.000513	0.026	CbGeAlD
Naltrexone—Libido decreased—Acamprosate—alcohol dependence	0.000513	0.00372	CcSEcCtD
Naltrexone—Increased appetite—Acamprosate—alcohol dependence	0.000506	0.00367	CcSEcCtD
Naltrexone—Thirst—Acamprosate—alcohol dependence	0.0005	0.00363	CcSEcCtD
Naltrexone—Nalbuphine—OPRK1—alcohol dependence	0.000494	0.061	CrCbGaD
Naltrexone—OPRM1—testis—alcohol dependence	0.00049	0.0248	CbGeAlD
Naltrexone—Arthritis—Acamprosate—alcohol dependence	0.000489	0.00355	CcSEcCtD
Naltrexone—Rhinorrhoea—Citalopram—alcohol dependence	0.000485	0.00352	CcSEcCtD
Naltrexone—Rigors—Citalopram—alcohol dependence	0.000481	0.00349	CcSEcCtD
Naltrexone—OPRM1—nervous system—alcohol dependence	0.000481	0.0244	CbGeAlD
Naltrexone—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.000477	0.00346	CcSEcCtD
Naltrexone—Dysphonia—Citalopram—alcohol dependence	0.000477	0.00346	CcSEcCtD
Naltrexone—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.000476	0.00345	CcSEcCtD
Naltrexone—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.000472	0.00342	CcSEcCtD
Naltrexone—Migraine—Acamprosate—alcohol dependence	0.000468	0.0034	CcSEcCtD
Naltrexone—Psychotic disorder—Acamprosate—alcohol dependence	0.000465	0.00337	CcSEcCtD
Naltrexone—OPRM1—central nervous system—alcohol dependence	0.000463	0.0235	CbGeAlD
Naltrexone—Face oedema—Acamprosate—alcohol dependence	0.000459	0.00333	CcSEcCtD
Naltrexone—Delirium—Citalopram—alcohol dependence	0.000457	0.00331	CcSEcCtD
Naltrexone—Disturbance in attention—Citalopram—alcohol dependence	0.000453	0.00329	CcSEcCtD
Naltrexone—Chest discomfort—Citalopram—alcohol dependence	0.000444	0.00322	CcSEcCtD
Naltrexone—Musculoskeletal stiffness—Citalopram—alcohol dependence	0.000438	0.00318	CcSEcCtD
Naltrexone—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.000435	0.00316	CcSEcCtD
Naltrexone—Cellulitis—Citalopram—alcohol dependence	0.000432	0.00313	CcSEcCtD
Naltrexone—Thinking abnormal—Citalopram—alcohol dependence	0.000429	0.00311	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.000428	0.00311	CcSEcCtD
Naltrexone—Paraesthesia—Disulfiram—alcohol dependence	0.000426	0.00309	CcSEcCtD
Naltrexone—Somnolence—Disulfiram—alcohol dependence	0.000422	0.00306	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.000419	0.00304	CcSEcCtD
Naltrexone—Hepatic enzyme increased—Citalopram—alcohol dependence	0.000415	0.00301	CcSEcCtD
Naltrexone—Hypercholesterolaemia—Citalopram—alcohol dependence	0.000415	0.00301	CcSEcCtD
Naltrexone—Influenza—Acamprosate—alcohol dependence	0.000411	0.00298	CcSEcCtD
Naltrexone—Fatigue—Disulfiram—alcohol dependence	0.000409	0.00297	CcSEcCtD
Naltrexone—Pain—Disulfiram—alcohol dependence	0.000406	0.00294	CcSEcCtD
Naltrexone—Oxymorphone—OPRK1—alcohol dependence	0.000402	0.0497	CrCbGaD
Naltrexone—Angina pectoris—Acamprosate—alcohol dependence	0.0004	0.00291	CcSEcCtD
Naltrexone—Muscle twitching—Citalopram—alcohol dependence	0.0004	0.0029	CcSEcCtD
Naltrexone—Bronchitis—Acamprosate—alcohol dependence	0.000395	0.00287	CcSEcCtD
Naltrexone—Blood pressure increased—Citalopram—alcohol dependence	0.000393	0.00285	CcSEcCtD
Naltrexone—Pulmonary embolism—Citalopram—alcohol dependence	0.000393	0.00285	CcSEcCtD
Naltrexone—Abnormal dreams—Citalopram—alcohol dependence	0.000388	0.00282	CcSEcCtD
Naltrexone—Butorphanol—OPRD1—alcohol dependence	0.00038	0.047	CrCbGaD
Naltrexone—Nightmare—Citalopram—alcohol dependence	0.000379	0.00275	CcSEcCtD
Naltrexone—Colitis—Citalopram—alcohol dependence	0.000377	0.00274	CcSEcCtD
Naltrexone—Weight increased—Acamprosate—alcohol dependence	0.000374	0.00271	CcSEcCtD
Naltrexone—Weight decreased—Acamprosate—alcohol dependence	0.000372	0.0027	CcSEcCtD
Naltrexone—Pneumonia—Acamprosate—alcohol dependence	0.000369	0.00267	CcSEcCtD
Naltrexone—OPRM1—brain—alcohol dependence	0.000367	0.0186	CbGeAlD
Naltrexone—Depression—Acamprosate—alcohol dependence	0.000365	0.00265	CcSEcCtD
Naltrexone—Acute coronary syndrome—Acamprosate—alcohol dependence	0.000361	0.00262	CcSEcCtD
Naltrexone—Myocardial infarction—Acamprosate—alcohol dependence	0.000359	0.00261	CcSEcCtD
Naltrexone—Urinary tract infection—Acamprosate—alcohol dependence	0.000356	0.00258	CcSEcCtD
Naltrexone—Hydrocodone—OPRK1—alcohol dependence	0.000352	0.0435	CrCbGaD
Naltrexone—Nalbuphine—OPRD1—alcohol dependence	0.000348	0.043	CrCbGaD
Naltrexone—Epistaxis—Acamprosate—alcohol dependence	0.000346	0.00251	CcSEcCtD
Naltrexone—Hyperkinesia—Citalopram—alcohol dependence	0.000343	0.00249	CcSEcCtD
Naltrexone—Mental disability—Citalopram—alcohol dependence	0.000341	0.00247	CcSEcCtD
Naltrexone—Asthenia—Disulfiram—alcohol dependence	0.00034	0.00247	CcSEcCtD
Naltrexone—Euphoric mood—Citalopram—alcohol dependence	0.000337	0.00245	CcSEcCtD
Naltrexone—Lymphadenopathy—Citalopram—alcohol dependence	0.000334	0.00242	CcSEcCtD
Naltrexone—Phlebitis—Citalopram—alcohol dependence	0.000331	0.0024	CcSEcCtD
Naltrexone—Sleep disorder—Citalopram—alcohol dependence	0.000329	0.00239	CcSEcCtD
Naltrexone—Hepatitis—Acamprosate—alcohol dependence	0.000329	0.00239	CcSEcCtD
Naltrexone—Hallucination—Acamprosate—alcohol dependence	0.000327	0.00238	CcSEcCtD
Naltrexone—Pharyngitis—Acamprosate—alcohol dependence	0.000327	0.00237	CcSEcCtD
Naltrexone—Gastroenteritis—Citalopram—alcohol dependence	0.000322	0.00233	CcSEcCtD
Naltrexone—Oxycodone—OPRK1—alcohol dependence	0.000321	0.0397	CrCbGaD
Naltrexone—Disorientation—Citalopram—alcohol dependence	0.000319	0.00231	CcSEcCtD
Naltrexone—Dizziness—Disulfiram—alcohol dependence	0.000314	0.00228	CcSEcCtD
Naltrexone—Nasal congestion—Citalopram—alcohol dependence	0.000313	0.00227	CcSEcCtD
Naltrexone—Libido decreased—Citalopram—alcohol dependence	0.000307	0.00223	CcSEcCtD
Naltrexone—Tinnitus—Acamprosate—alcohol dependence	0.000307	0.00223	CcSEcCtD
Naltrexone—Hot flush—Citalopram—alcohol dependence	0.000305	0.00221	CcSEcCtD
Naltrexone—Increased appetite—Citalopram—alcohol dependence	0.000303	0.0022	CcSEcCtD
Naltrexone—Menopausal symptoms—Citalopram—alcohol dependence	0.000302	0.00219	CcSEcCtD
Naltrexone—Atrial fibrillation—Citalopram—alcohol dependence	0.000301	0.00218	CcSEcCtD
Naltrexone—Thirst—Citalopram—alcohol dependence	0.0003	0.00217	CcSEcCtD
Naltrexone—Rash—Disulfiram—alcohol dependence	0.000299	0.00217	CcSEcCtD
Naltrexone—Headache—Disulfiram—alcohol dependence	0.000297	0.00216	CcSEcCtD
Naltrexone—Immune system disorder—Acamprosate—alcohol dependence	0.000297	0.00216	CcSEcCtD
Naltrexone—Purpura—Citalopram—alcohol dependence	0.000296	0.00215	CcSEcCtD
Naltrexone—Buprenorphine—OPRK1—alcohol dependence	0.000296	0.0365	CrCbGaD
Naltrexone—Chills—Acamprosate—alcohol dependence	0.000295	0.00214	CcSEcCtD
Naltrexone—Naloxone—OPRK1—alcohol dependence	0.000294	0.0363	CrCbGaD
Naltrexone—Arthritis—Citalopram—alcohol dependence	0.000293	0.00213	CcSEcCtD
Naltrexone—Hydromorphone—OPRK1—alcohol dependence	0.000291	0.036	CrCbGaD
Naltrexone—Methylnaltrexone—OPRM1—alcohol dependence	0.000291	0.036	CrCbGaD
Naltrexone—Butorphanol—OPRM1—alcohol dependence	0.000291	0.036	CrCbGaD
Naltrexone—Lethargy—Citalopram—alcohol dependence	0.000291	0.00211	CcSEcCtD
Naltrexone—Alopecia—Acamprosate—alcohol dependence	0.000291	0.00211	CcSEcCtD
Naltrexone—Mental disorder—Acamprosate—alcohol dependence	0.000288	0.00209	CcSEcCtD
Naltrexone—Malnutrition—Acamprosate—alcohol dependence	0.000286	0.00208	CcSEcCtD
Naltrexone—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000285	0.00207	CcSEcCtD
Naltrexone—Pain in extremity—Citalopram—alcohol dependence	0.000285	0.00207	CcSEcCtD
Naltrexone—Oxymorphone—OPRD1—alcohol dependence	0.000284	0.035	CrCbGaD
Naltrexone—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000283	0.00205	CcSEcCtD
Naltrexone—Flatulence—Acamprosate—alcohol dependence	0.000282	0.00205	CcSEcCtD
Naltrexone—Tension—Acamprosate—alcohol dependence	0.000281	0.00204	CcSEcCtD
Naltrexone—Migraine—Citalopram—alcohol dependence	0.000281	0.00204	CcSEcCtD
Naltrexone—Dysgeusia—Acamprosate—alcohol dependence	0.00028	0.00204	CcSEcCtD
Naltrexone—Psychotic disorder—Citalopram—alcohol dependence	0.000278	0.00202	CcSEcCtD
Naltrexone—Nervousness—Acamprosate—alcohol dependence	0.000278	0.00202	CcSEcCtD
Naltrexone—Back pain—Acamprosate—alcohol dependence	0.000277	0.00201	CcSEcCtD
Naltrexone—Muscle spasms—Acamprosate—alcohol dependence	0.000275	0.002	CcSEcCtD
Naltrexone—Face oedema—Citalopram—alcohol dependence	0.000275	0.002	CcSEcCtD
Naltrexone—Irritability—Citalopram—alcohol dependence	0.000272	0.00197	CcSEcCtD
Naltrexone—Tremor—Acamprosate—alcohol dependence	0.000268	0.00195	CcSEcCtD
Naltrexone—Nalbuphine—OPRM1—alcohol dependence	0.000266	0.0329	CrCbGaD
Naltrexone—Ill-defined disorder—Acamprosate—alcohol dependence	0.000266	0.00193	CcSEcCtD
Naltrexone—Dehydration—Citalopram—alcohol dependence	0.000265	0.00192	CcSEcCtD
Naltrexone—Agitation—Acamprosate—alcohol dependence	0.000263	0.00191	CcSEcCtD
Naltrexone—Angioedema—Acamprosate—alcohol dependence	0.000262	0.0019	CcSEcCtD
Naltrexone—Abdominal pain upper—Citalopram—alcohol dependence	0.00026	0.00189	CcSEcCtD
Naltrexone—Malaise—Acamprosate—alcohol dependence	0.000258	0.00187	CcSEcCtD
Naltrexone—Syncope—Acamprosate—alcohol dependence	0.000257	0.00186	CcSEcCtD
Naltrexone—Cramp muscle—Citalopram—alcohol dependence	0.000257	0.00186	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000257	0.00186	CcSEcCtD
Naltrexone—ABCB1—forebrain—alcohol dependence	0.000255	0.0129	CbGeAlD
Naltrexone—Nasopharyngitis—Citalopram—alcohol dependence	0.000255	0.00185	CcSEcCtD
Naltrexone—Palpitations—Acamprosate—alcohol dependence	0.000253	0.00184	CcSEcCtD
Naltrexone—Loss of consciousness—Acamprosate—alcohol dependence	0.000252	0.00183	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000251	0.00182	CcSEcCtD
Naltrexone—Cough—Acamprosate—alcohol dependence	0.00025	0.00181	CcSEcCtD
Naltrexone—Convulsion—Acamprosate—alcohol dependence	0.000248	0.0018	CcSEcCtD
Naltrexone—Morphine—OPRK1—alcohol dependence	0.000248	0.0306	CrCbGaD
Naltrexone—Hydrocodone—OPRD1—alcohol dependence	0.000248	0.0306	CrCbGaD
Naltrexone—Hypertension—Acamprosate—alcohol dependence	0.000247	0.00179	CcSEcCtD
Naltrexone—Influenza—Citalopram—alcohol dependence	0.000246	0.00179	CcSEcCtD
Naltrexone—Myalgia—Acamprosate—alcohol dependence	0.000244	0.00177	CcSEcCtD
Naltrexone—Chest pain—Acamprosate—alcohol dependence	0.000244	0.00177	CcSEcCtD
Naltrexone—Arthralgia—Acamprosate—alcohol dependence	0.000244	0.00177	CcSEcCtD
Naltrexone—Anxiety—Acamprosate—alcohol dependence	0.000243	0.00176	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000242	0.00176	CcSEcCtD
Naltrexone—Discomfort—Acamprosate—alcohol dependence	0.000241	0.00175	CcSEcCtD
Naltrexone—Angina pectoris—Citalopram—alcohol dependence	0.00024	0.00174	CcSEcCtD
Naltrexone—Sweating increased—Citalopram—alcohol dependence	0.00024	0.00174	CcSEcCtD
Naltrexone—Dry mouth—Acamprosate—alcohol dependence	0.000238	0.00173	CcSEcCtD
Naltrexone—Bronchitis—Citalopram—alcohol dependence	0.000237	0.00172	CcSEcCtD
Naltrexone—ABCB1—adrenal cortex—alcohol dependence	0.000237	0.012	CbGeAlD
Naltrexone—Abdominal discomfort—Citalopram—alcohol dependence	0.000236	0.00171	CcSEcCtD
Naltrexone—Confusional state—Acamprosate—alcohol dependence	0.000236	0.00171	CcSEcCtD
Naltrexone—Anaphylactic shock—Acamprosate—alcohol dependence	0.000234	0.0017	CcSEcCtD
Naltrexone—Infection—Acamprosate—alcohol dependence	0.000232	0.00169	CcSEcCtD
Naltrexone—Shock—Acamprosate—alcohol dependence	0.00023	0.00167	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000229	0.00166	CcSEcCtD
Naltrexone—Tachycardia—Acamprosate—alcohol dependence	0.000228	0.00166	CcSEcCtD
Naltrexone—Skin disorder—Acamprosate—alcohol dependence	0.000227	0.00165	CcSEcCtD
Naltrexone—Oxycodone—OPRD1—alcohol dependence	0.000226	0.0279	CrCbGaD
Naltrexone—Hyperhidrosis—Acamprosate—alcohol dependence	0.000226	0.00164	CcSEcCtD
Naltrexone—Weight increased—Citalopram—alcohol dependence	0.000224	0.00163	CcSEcCtD
Naltrexone—Weight decreased—Citalopram—alcohol dependence	0.000223	0.00162	CcSEcCtD
Naltrexone—Anorexia—Acamprosate—alcohol dependence	0.000223	0.00162	CcSEcCtD
Naltrexone—Pneumonia—Citalopram—alcohol dependence	0.000221	0.0016	CcSEcCtD
Naltrexone—Infestation—Citalopram—alcohol dependence	0.00022	0.00159	CcSEcCtD
Naltrexone—Infestation NOS—Citalopram—alcohol dependence	0.00022	0.00159	CcSEcCtD
Naltrexone—Depression—Citalopram—alcohol dependence	0.000219	0.00159	CcSEcCtD
Naltrexone—Oxymorphone—OPRM1—alcohol dependence	0.000217	0.0268	CrCbGaD
Naltrexone—Acute coronary syndrome—Citalopram—alcohol dependence	0.000217	0.00157	CcSEcCtD
Naltrexone—ABCB1—cardiovascular system—alcohol dependence	0.000216	0.0109	CbGeAlD
Naltrexone—Myocardial infarction—Citalopram—alcohol dependence	0.000215	0.00156	CcSEcCtD
Naltrexone—Urinary tract infection—Citalopram—alcohol dependence	0.000214	0.00155	CcSEcCtD
Naltrexone—Conjunctivitis—Citalopram—alcohol dependence	0.000214	0.00155	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000213	0.00155	CcSEcCtD
Naltrexone—Insomnia—Acamprosate—alcohol dependence	0.000211	0.00153	CcSEcCtD
Naltrexone—Paraesthesia—Acamprosate—alcohol dependence	0.00021	0.00152	CcSEcCtD
Naltrexone—ABCB1—pancreas—alcohol dependence	0.00021	0.0106	CbGeAlD
Naltrexone—Dyspnoea—Acamprosate—alcohol dependence	0.000208	0.00151	CcSEcCtD
Naltrexone—Buprenorphine—OPRD1—alcohol dependence	0.000208	0.0257	CrCbGaD
Naltrexone—Somnolence—Acamprosate—alcohol dependence	0.000208	0.00151	CcSEcCtD
Naltrexone—Hepatobiliary disease—Citalopram—alcohol dependence	0.000208	0.00151	CcSEcCtD
Naltrexone—Epistaxis—Citalopram—alcohol dependence	0.000207	0.0015	CcSEcCtD
Naltrexone—Naloxone—OPRD1—alcohol dependence	0.000207	0.0256	CrCbGaD
Naltrexone—Sinusitis—Citalopram—alcohol dependence	0.000206	0.0015	CcSEcCtD
Naltrexone—Hydromorphone—OPRD1—alcohol dependence	0.000205	0.0254	CrCbGaD
Naltrexone—Decreased appetite—Acamprosate—alcohol dependence	0.000203	0.00147	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000202	0.00146	CcSEcCtD
Naltrexone—Pain—Acamprosate—alcohol dependence	0.0002	0.00145	CcSEcCtD
Naltrexone—Constipation—Acamprosate—alcohol dependence	0.0002	0.00145	CcSEcCtD
Naltrexone—Hepatitis—Citalopram—alcohol dependence	0.000197	0.00143	CcSEcCtD
Naltrexone—Hallucination—Citalopram—alcohol dependence	0.000196	0.00142	CcSEcCtD
Naltrexone—ABCB1—gonad—alcohol dependence	0.000196	0.00994	CbGeAlD
Naltrexone—Pharyngitis—Citalopram—alcohol dependence	0.000196	0.00142	CcSEcCtD
Naltrexone—Connective tissue disorder—Citalopram—alcohol dependence	0.000194	0.00141	CcSEcCtD
Naltrexone—Feeling abnormal—Acamprosate—alcohol dependence	0.000193	0.0014	CcSEcCtD
Naltrexone—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000191	0.00139	CcSEcCtD
Naltrexone—Hydrocodone—OPRM1—alcohol dependence	0.00019	0.0234	CrCbGaD
Naltrexone—Urticaria—Acamprosate—alcohol dependence	0.000186	0.00135	CcSEcCtD
Naltrexone—Abdominal pain—Acamprosate—alcohol dependence	0.000185	0.00134	CcSEcCtD
Naltrexone—Body temperature increased—Acamprosate—alcohol dependence	0.000185	0.00134	CcSEcCtD
Naltrexone—Eye disorder—Citalopram—alcohol dependence	0.000184	0.00134	CcSEcCtD
Naltrexone—Tinnitus—Citalopram—alcohol dependence	0.000184	0.00133	CcSEcCtD
Naltrexone—Cardiac disorder—Citalopram—alcohol dependence	0.000183	0.00133	CcSEcCtD
Naltrexone—ABCB1—digestive system—alcohol dependence	0.000179	0.00909	CbGeAlD
Naltrexone—Angiopathy—Citalopram—alcohol dependence	0.000179	0.0013	CcSEcCtD
Naltrexone—Immune system disorder—Citalopram—alcohol dependence	0.000178	0.00129	CcSEcCtD
Naltrexone—Mediastinal disorder—Citalopram—alcohol dependence	0.000178	0.00129	CcSEcCtD
Naltrexone—Chills—Citalopram—alcohol dependence	0.000177	0.00128	CcSEcCtD
Naltrexone—Morphine—OPRD1—alcohol dependence	0.000175	0.0216	CrCbGaD
Naltrexone—Alopecia—Citalopram—alcohol dependence	0.000174	0.00126	CcSEcCtD
Naltrexone—Oxycodone—OPRM1—alcohol dependence	0.000173	0.0214	CrCbGaD
Naltrexone—Mental disorder—Citalopram—alcohol dependence	0.000173	0.00125	CcSEcCtD
Naltrexone—Hypersensitivity—Acamprosate—alcohol dependence	0.000172	0.00125	CcSEcCtD
Naltrexone—Malnutrition—Citalopram—alcohol dependence	0.000172	0.00125	CcSEcCtD
Naltrexone—ABCB1—blood—alcohol dependence	0.000171	0.00866	CbGeAlD
Naltrexone—Flatulence—Citalopram—alcohol dependence	0.000169	0.00123	CcSEcCtD
Naltrexone—ABCB1—midbrain—alcohol dependence	0.000169	0.00855	CbGeAlD
Naltrexone—Tension—Citalopram—alcohol dependence	0.000168	0.00122	CcSEcCtD
Naltrexone—Dysgeusia—Citalopram—alcohol dependence	0.000168	0.00122	CcSEcCtD
Naltrexone—Asthenia—Acamprosate—alcohol dependence	0.000168	0.00122	CcSEcCtD
Naltrexone—Nervousness—Citalopram—alcohol dependence	0.000167	0.00121	CcSEcCtD
Naltrexone—Back pain—Citalopram—alcohol dependence	0.000166	0.00121	CcSEcCtD
Naltrexone—Pruritus—Acamprosate—alcohol dependence	0.000165	0.0012	CcSEcCtD
Naltrexone—Muscle spasms—Citalopram—alcohol dependence	0.000165	0.0012	CcSEcCtD
Naltrexone—Vision blurred—Citalopram—alcohol dependence	0.000162	0.00117	CcSEcCtD
Naltrexone—Tremor—Citalopram—alcohol dependence	0.000161	0.00117	CcSEcCtD
Naltrexone—Diarrhoea—Acamprosate—alcohol dependence	0.00016	0.00116	CcSEcCtD
Naltrexone—Buprenorphine—OPRM1—alcohol dependence	0.000159	0.0197	CrCbGaD
Naltrexone—Ill-defined disorder—Citalopram—alcohol dependence	0.000159	0.00116	CcSEcCtD
Naltrexone—Naloxone—OPRM1—alcohol dependence	0.000158	0.0196	CrCbGaD
Naltrexone—Agitation—Citalopram—alcohol dependence	0.000158	0.00114	CcSEcCtD
Naltrexone—Hydromorphone—OPRM1—alcohol dependence	0.000157	0.0194	CrCbGaD
Naltrexone—Angioedema—Citalopram—alcohol dependence	0.000157	0.00114	CcSEcCtD
Naltrexone—Malaise—Citalopram—alcohol dependence	0.000155	0.00112	CcSEcCtD
Naltrexone—Dizziness—Acamprosate—alcohol dependence	0.000155	0.00112	CcSEcCtD
Naltrexone—Syncope—Citalopram—alcohol dependence	0.000154	0.00112	CcSEcCtD
Naltrexone—Palpitations—Citalopram—alcohol dependence	0.000152	0.0011	CcSEcCtD
Naltrexone—Loss of consciousness—Citalopram—alcohol dependence	0.000151	0.0011	CcSEcCtD
Naltrexone—Cough—Citalopram—alcohol dependence	0.00015	0.00109	CcSEcCtD
Naltrexone—Convulsion—Citalopram—alcohol dependence	0.000149	0.00108	CcSEcCtD
Naltrexone—Vomiting—Acamprosate—alcohol dependence	0.000149	0.00108	CcSEcCtD
Naltrexone—Hypertension—Citalopram—alcohol dependence	0.000148	0.00108	CcSEcCtD
Naltrexone—ABCB1—endocrine gland—alcohol dependence	0.000148	0.00751	CbGeAlD
Naltrexone—Rash—Acamprosate—alcohol dependence	0.000147	0.00107	CcSEcCtD
Naltrexone—Dermatitis—Acamprosate—alcohol dependence	0.000147	0.00107	CcSEcCtD
Naltrexone—Headache—Acamprosate—alcohol dependence	0.000146	0.00106	CcSEcCtD
Naltrexone—Arthralgia—Citalopram—alcohol dependence	0.000146	0.00106	CcSEcCtD
Naltrexone—Chest pain—Citalopram—alcohol dependence	0.000146	0.00106	CcSEcCtD
Naltrexone—Myalgia—Citalopram—alcohol dependence	0.000146	0.00106	CcSEcCtD
Naltrexone—Anxiety—Citalopram—alcohol dependence	0.000146	0.00106	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000145	0.00105	CcSEcCtD
Naltrexone—Discomfort—Citalopram—alcohol dependence	0.000144	0.00105	CcSEcCtD
Naltrexone—Dry mouth—Citalopram—alcohol dependence	0.000143	0.00104	CcSEcCtD
Naltrexone—Confusional state—Citalopram—alcohol dependence	0.000141	0.00103	CcSEcCtD
Naltrexone—ABCB1—testis—alcohol dependence	0.000141	0.00716	CbGeAlD
Naltrexone—Anaphylactic shock—Citalopram—alcohol dependence	0.00014	0.00102	CcSEcCtD
Naltrexone—Oedema—Citalopram—alcohol dependence	0.00014	0.00102	CcSEcCtD
Naltrexone—Infection—Citalopram—alcohol dependence	0.000139	0.00101	CcSEcCtD
Naltrexone—Nausea—Acamprosate—alcohol dependence	0.000139	0.00101	CcSEcCtD
Naltrexone—ABCB1—nervous system—alcohol dependence	0.000139	0.00703	CbGeAlD
Naltrexone—Shock—Citalopram—alcohol dependence	0.000138	0.001	CcSEcCtD
Naltrexone—Nervous system disorder—Citalopram—alcohol dependence	0.000137	0.000997	CcSEcCtD
Naltrexone—Tachycardia—Citalopram—alcohol dependence	0.000137	0.000992	CcSEcCtD
Naltrexone—Skin disorder—Citalopram—alcohol dependence	0.000136	0.000988	CcSEcCtD
Naltrexone—Hyperhidrosis—Citalopram—alcohol dependence	0.000135	0.000983	CcSEcCtD
Naltrexone—Morphine—OPRM1—alcohol dependence	0.000134	0.0165	CrCbGaD
Naltrexone—Anorexia—Citalopram—alcohol dependence	0.000134	0.000969	CcSEcCtD
Naltrexone—ABCB1—liver—alcohol dependence	0.000133	0.00677	CbGeAlD
Naltrexone—ABCB1—central nervous system—alcohol dependence	0.000133	0.00677	CbGeAlD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000132	0.0026	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000132	0.0026	CbGpPWpGaD
Naltrexone—ABCB1—cerebellum—alcohol dependence	0.00013	0.00662	CbGeAlD
Naltrexone—OPRM1—GPCR ligand binding—PDYN—alcohol dependence	0.000128	0.00253	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—NPY—alcohol dependence	0.000128	0.00252	CbGpPWpGaD
Naltrexone—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000128	0.000926	CcSEcCtD
Naltrexone—Insomnia—Citalopram—alcohol dependence	0.000127	0.00092	CcSEcCtD
Naltrexone—OPRM1—G alpha (i) signalling events—CNR1—alcohol dependence	0.000126	0.00248	CbGpPWpGaD
Naltrexone—Paraesthesia—Citalopram—alcohol dependence	0.000126	0.000913	CcSEcCtD
Naltrexone—Dyspnoea—Citalopram—alcohol dependence	0.000125	0.000907	CcSEcCtD
Naltrexone—Somnolence—Citalopram—alcohol dependence	0.000125	0.000904	CcSEcCtD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000124	0.00245	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000124	0.00245	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CRH—alcohol dependence	0.000123	0.00243	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR1B—alcohol dependence	0.000123	0.00243	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—DRD2—alcohol dependence	0.000123	0.00242	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—AVP—alcohol dependence	0.000123	0.00242	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000122	0.00241	CbGpPWpGaD
Naltrexone—Decreased appetite—Citalopram—alcohol dependence	0.000122	0.000884	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—OPRM1—alcohol dependence	0.000122	0.0024	CbGpPWpGaD
Naltrexone—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000121	0.000878	CcSEcCtD
Naltrexone—Fatigue—Citalopram—alcohol dependence	0.000121	0.000877	CcSEcCtD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00012	0.00237	CbGpPWpGaD
Naltrexone—Constipation—Citalopram—alcohol dependence	0.00012	0.000869	CcSEcCtD
Naltrexone—Pain—Citalopram—alcohol dependence	0.00012	0.000869	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—CRHR1—alcohol dependence	0.000119	0.00235	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000118	0.00234	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000117	0.0023	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000116	0.00228	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000116	0.00228	CbGpPWpGaD
Naltrexone—Feeling abnormal—Citalopram—alcohol dependence	0.000115	0.000838	CcSEcCtD
Naltrexone—Gastrointestinal pain—Citalopram—alcohol dependence	0.000115	0.000831	CcSEcCtD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000114	0.00225	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000114	0.00225	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—OPRK1—alcohol dependence	0.000112	0.00222	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CHRM2—alcohol dependence	0.000112	0.00221	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—NPY—alcohol dependence	0.000112	0.00221	CbGpPWpGaD
Naltrexone—Urticaria—Citalopram—alcohol dependence	0.000111	0.000808	CcSEcCtD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000111	0.00219	CbGpPWpGaD
Naltrexone—Body temperature increased—Citalopram—alcohol dependence	0.000111	0.000804	CcSEcCtD
Naltrexone—Abdominal pain—Citalopram—alcohol dependence	0.000111	0.000804	CcSEcCtD
Naltrexone—OPRD1—Peptide ligand-binding receptors—POMC—alcohol dependence	0.00011	0.00217	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CRH—alcohol dependence	0.000108	0.00213	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR1B—alcohol dependence	0.000108	0.00213	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000108	0.00212	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—DRD4—alcohol dependence	0.000108	0.00212	CbGpPWpGaD
Naltrexone—ABCB1—brain—alcohol dependence	0.000106	0.00537	CbGeAlD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000105	0.00207	CbGpPWpGaD
Naltrexone—Hypersensitivity—Citalopram—alcohol dependence	0.000103	0.000749	CcSEcCtD
Naltrexone—OPRD1—GPCR ligand binding—CNR1—alcohol dependence	0.000103	0.00203	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—OPRK1—alcohol dependence	0.000102	0.00201	CbGpPWpGaD
Naltrexone—Asthenia—Citalopram—alcohol dependence	0.000101	0.00073	CcSEcCtD
Naltrexone—OPRD1—GPCR ligand binding—DRD2—alcohol dependence	0.0001	0.00198	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR7—alcohol dependence	0.0001	0.00198	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.0001	0.00197	CbGpPWpGaD
Naltrexone—Pruritus—Citalopram—alcohol dependence	9.91e-05	0.000719	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—PDYN—alcohol dependence	9.78e-05	0.00193	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	9.77e-05	0.00193	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	9.77e-05	0.00193	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADH6—alcohol dependence	9.74e-05	0.00192	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	9.73e-05	0.00192	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—POMC—alcohol dependence	9.64e-05	0.0019	CbGpPWpGaD
Naltrexone—Diarrhoea—Citalopram—alcohol dependence	9.59e-05	0.000696	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—NPY—alcohol dependence	9.47e-05	0.00187	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	9.45e-05	0.00186	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—DRD4—alcohol dependence	9.45e-05	0.00186	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—POMC—alcohol dependence	9.28e-05	0.00183	CbGpPWpGaD
Naltrexone—Dizziness—Citalopram—alcohol dependence	9.27e-05	0.000672	CcSEcCtD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	9.23e-05	0.00182	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CRH—alcohol dependence	9.14e-05	0.0018	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR1B—alcohol dependence	9.14e-05	0.0018	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CRHR1—alcohol dependence	9.09e-05	0.00179	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CNR1—alcohol dependence	9.02e-05	0.00178	CbGpPWpGaD
Naltrexone—UGT1A1—Biological oxidations—POMC—alcohol dependence	9.02e-05	0.00178	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—OPRD1—alcohol dependence	8.94e-05	0.00176	CbGpPWpGaD
Naltrexone—Vomiting—Citalopram—alcohol dependence	8.91e-05	0.000646	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—PDYN—alcohol dependence	8.88e-05	0.00175	CbGpPWpGaD
Naltrexone—Rash—Citalopram—alcohol dependence	8.84e-05	0.000641	CcSEcCtD
Naltrexone—Dermatitis—Citalopram—alcohol dependence	8.83e-05	0.000641	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—HTR7—alcohol dependence	8.8e-05	0.00174	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—DRD2—alcohol dependence	8.8e-05	0.00174	CbGpPWpGaD
Naltrexone—Headache—Citalopram—alcohol dependence	8.78e-05	0.000637	CcSEcCtD
Naltrexone—OPRK1—GPCR downstream signaling—PDYN—alcohol dependence	8.57e-05	0.00169	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CHRM2—alcohol dependence	8.55e-05	0.00168	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—AVP—alcohol dependence	8.45e-05	0.00167	CbGpPWpGaD
Naltrexone—Nausea—Citalopram—alcohol dependence	8.32e-05	0.000604	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—CRHR1—alcohol dependence	8.26e-05	0.00163	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	8.22e-05	0.00162	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—POMC—alcohol dependence	8.15e-05	0.00161	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—OPRK1—alcohol dependence	8.14e-05	0.0016	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—POMC—alcohol dependence	8.13e-05	0.0016	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—OPRD1—alcohol dependence	8.12e-05	0.0016	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	8.1e-05	0.0016	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADH1A—alcohol dependence	8.07e-05	0.00159	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	7.99e-05	0.00157	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD4—alcohol dependence	7.99e-05	0.00157	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CRHR1—alcohol dependence	7.97e-05	0.00157	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—OPRM1—alcohol dependence	7.85e-05	0.00155	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PDYN—alcohol dependence	7.79e-05	0.00153	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CHRM2—alcohol dependence	7.76e-05	0.00153	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CNR1—alcohol dependence	7.63e-05	0.0015	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—OPRD1—alcohol dependence	7.56e-05	0.00149	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CHRM2—alcohol dependence	7.5e-05	0.00148	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—DRD2—alcohol dependence	7.44e-05	0.00147	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR7—alcohol dependence	7.44e-05	0.00147	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—AVP—alcohol dependence	7.41e-05	0.00146	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	7.37e-05	0.00145	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PDYN—alcohol dependence	7.25e-05	0.00143	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CRHR1—alcohol dependence	7.24e-05	0.00143	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—NPY—alcohol dependence	7.22e-05	0.00142	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—OPRM1—alcohol dependence	7.13e-05	0.0014	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR2A—alcohol dependence	7.03e-05	0.00139	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR1B—alcohol dependence	6.97e-05	0.00137	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CRH—alcohol dependence	6.97e-05	0.00137	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—OPRM1—alcohol dependence	6.88e-05	0.00136	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—POMC—alcohol dependence	6.87e-05	0.00135	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—OPRD1—alcohol dependence	6.86e-05	0.00135	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADH4—alcohol dependence	6.86e-05	0.00135	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	6.84e-05	0.00135	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CHRM2—alcohol dependence	6.81e-05	0.00134	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CRHR1—alcohol dependence	6.74e-05	0.00133	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PDYN—alcohol dependence	6.58e-05	0.0013	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—NPY—alcohol dependence	6.56e-05	0.00129	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	6.47e-05	0.00127	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CHRM2—alcohol dependence	6.33e-05	0.00125	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—NPY—alcohol dependence	6.33e-05	0.00125	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CRH—alcohol dependence	6.33e-05	0.00125	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR1B—alcohol dependence	6.33e-05	0.00125	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—AVP—alcohol dependence	6.26e-05	0.00123	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—OPRM1—alcohol dependence	6.25e-05	0.00123	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR2A—alcohol dependence	6.17e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CRHR1—alcohol dependence	6.12e-05	0.00121	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR1B—alcohol dependence	6.11e-05	0.0012	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CRH—alcohol dependence	6.11e-05	0.0012	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD4—alcohol dependence	6.09e-05	0.0012	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—OPRK1—alcohol dependence	6.03e-05	0.00119	CbGpPWpGaD
Naltrexone—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	5.91e-05	0.00116	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADH7—alcohol dependence	5.83e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CNR1—alcohol dependence	5.82e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CHRM2—alcohol dependence	5.75e-05	0.00113	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—NPY—alcohol dependence	5.75e-05	0.00113	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	5.71e-05	0.00113	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—DRD2—alcohol dependence	5.67e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR7—alcohol dependence	5.67e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—POMC—alcohol dependence	5.62e-05	0.00111	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GGT2—alcohol dependence	5.59e-05	0.0011	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR1B—alcohol dependence	5.55e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CRH—alcohol dependence	5.55e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD4—alcohol dependence	5.53e-05	0.00109	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	5.47e-05	0.00108	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—NPY—alcohol dependence	5.35e-05	0.00106	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD4—alcohol dependence	5.34e-05	0.00105	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CNR1—alcohol dependence	5.28e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PDYN—alcohol dependence	5.25e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2A—alcohol dependence	5.21e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CRH—alcohol dependence	5.16e-05	0.00102	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR1B—alcohol dependence	5.16e-05	0.00102	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR7—alcohol dependence	5.15e-05	0.00102	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—DRD2—alcohol dependence	5.15e-05	0.00102	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADH1B—alcohol dependence	5.11e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CNR1—alcohol dependence	5.1e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—DRD2—alcohol dependence	4.98e-05	0.000981	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR7—alcohol dependence	4.98e-05	0.000981	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—POMC—alcohol dependence	4.92e-05	0.000971	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CRHR1—alcohol dependence	4.88e-05	0.000961	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—WASF2—alcohol dependence	4.88e-05	0.000961	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—NPY—alcohol dependence	4.86e-05	0.000958	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	4.86e-05	0.000957	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD4—alcohol dependence	4.85e-05	0.000956	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—OPRD1—alcohol dependence	4.8e-05	0.000946	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—AVP—alcohol dependence	4.78e-05	0.000941	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CRH—alcohol dependence	4.69e-05	0.000924	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR1B—alcohol dependence	4.69e-05	0.000924	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—WASF1—alcohol dependence	4.68e-05	0.000922	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CNR1—alcohol dependence	4.63e-05	0.000913	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDYN—alcohol dependence	4.6e-05	0.000907	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CHRM2—alcohol dependence	4.59e-05	0.000904	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—DRD2—alcohol dependence	4.52e-05	0.000891	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR7—alcohol dependence	4.52e-05	0.000891	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD4—alcohol dependence	4.51e-05	0.00089	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH6—alcohol dependence	4.47e-05	0.00088	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—AVP—alcohol dependence	4.34e-05	0.000855	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CNR1—alcohol dependence	4.31e-05	0.00085	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CRHR1—alcohol dependence	4.28e-05	0.000843	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—WASF2—alcohol dependence	4.28e-05	0.000843	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOB—alcohol dependence	4.24e-05	0.000835	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—OPRM1—alcohol dependence	4.21e-05	0.00083	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—DRD2—alcohol dependence	4.2e-05	0.000829	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR7—alcohol dependence	4.2e-05	0.000829	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—AVP—alcohol dependence	4.19e-05	0.000825	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—POMC—alcohol dependence	4.16e-05	0.00082	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—WASF1—alcohol dependence	4.1e-05	0.000808	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD4—alcohol dependence	4.1e-05	0.000808	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—OPRD1—alcohol dependence	4.05e-05	0.000799	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CHRM2—alcohol dependence	4.02e-05	0.000793	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2A—alcohol dependence	3.97e-05	0.000783	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CNR1—alcohol dependence	3.91e-05	0.000771	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDYN—alcohol dependence	3.89e-05	0.000766	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NPY—alcohol dependence	3.87e-05	0.000764	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR7—alcohol dependence	3.82e-05	0.000753	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—DRD2—alcohol dependence	3.82e-05	0.000753	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—AVP—alcohol dependence	3.8e-05	0.00075	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CRH—alcohol dependence	3.74e-05	0.000737	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR1B—alcohol dependence	3.74e-05	0.000737	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH1A—alcohol dependence	3.7e-05	0.000729	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—OPRM1—alcohol dependence	3.69e-05	0.000728	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—WASF2—alcohol dependence	3.61e-05	0.000712	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CRHR1—alcohol dependence	3.61e-05	0.000712	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2A—alcohol dependence	3.61e-05	0.000711	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALDH2—alcohol dependence	3.6e-05	0.00071	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—AVP—alcohol dependence	3.54e-05	0.000698	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2A—alcohol dependence	3.48e-05	0.000687	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—WASF1—alcohol dependence	3.47e-05	0.000683	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CHRM2—alcohol dependence	3.4e-05	0.00067	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NPY—alcohol dependence	3.4e-05	0.00067	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR1B—alcohol dependence	3.28e-05	0.000646	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CRH—alcohol dependence	3.28e-05	0.000646	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD4—alcohol dependence	3.27e-05	0.000644	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—AVP—alcohol dependence	3.21e-05	0.000634	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—POMC—alcohol dependence	3.17e-05	0.000626	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2A—alcohol dependence	3.16e-05	0.000624	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH4—alcohol dependence	3.15e-05	0.00062	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CNR1—alcohol dependence	3.12e-05	0.000615	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GOT2—alcohol dependence	3.06e-05	0.000604	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR7—alcohol dependence	3.04e-05	0.0006	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—DRD2—alcohol dependence	3.04e-05	0.0006	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2A—alcohol dependence	2.94e-05	0.00058	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—POMC—alcohol dependence	2.88e-05	0.000568	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CYP2E1—alcohol dependence	2.88e-05	0.000568	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NPY—alcohol dependence	2.87e-05	0.000566	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD4—alcohol dependence	2.86e-05	0.000565	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—POMC—alcohol dependence	2.78e-05	0.000549	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR1B—alcohol dependence	2.77e-05	0.000546	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CRH—alcohol dependence	2.77e-05	0.000546	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.75e-05	0.000542	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CNR1—alcohol dependence	2.74e-05	0.000539	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH7—alcohol dependence	2.68e-05	0.000527	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2A—alcohol dependence	2.67e-05	0.000527	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR7—alcohol dependence	2.67e-05	0.000526	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—DRD2—alcohol dependence	2.67e-05	0.000526	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GGT1—alcohol dependence	2.64e-05	0.000521	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GOT1—alcohol dependence	2.64e-05	0.000521	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GGT2—alcohol dependence	2.57e-05	0.000506	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—AVP—alcohol dependence	2.56e-05	0.000505	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—POMC—alcohol dependence	2.53e-05	0.000498	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.52e-05	0.000498	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD4—alcohol dependence	2.42e-05	0.000477	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOA—alcohol dependence	2.37e-05	0.000467	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—POMC—alcohol dependence	2.35e-05	0.000464	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADH1B—alcohol dependence	2.35e-05	0.000462	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CNR1—alcohol dependence	2.31e-05	0.000456	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	2.27e-05	0.000448	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR7—alcohol dependence	2.26e-05	0.000445	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—DRD2—alcohol dependence	2.26e-05	0.000445	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AVP—alcohol dependence	2.25e-05	0.000443	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—POMC—alcohol dependence	2.14e-05	0.000421	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2A—alcohol dependence	2.13e-05	0.00042	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOB—alcohol dependence	1.94e-05	0.000383	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AVP—alcohol dependence	1.9e-05	0.000374	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—alcohol dependence	1.87e-05	0.000368	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—alcohol dependence	1.7e-05	0.000336	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALDH2—alcohol dependence	1.65e-05	0.000326	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—alcohol dependence	1.58e-05	0.000311	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—alcohol dependence	1.54e-05	0.000304	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—alcohol dependence	1.49e-05	0.000294	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GOT2—alcohol dependence	1.41e-05	0.000277	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.32e-05	0.00026	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—alcohol dependence	1.26e-05	0.000249	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GOT1—alcohol dependence	1.21e-05	0.000239	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GGT1—alcohol dependence	1.21e-05	0.000239	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EP300—alcohol dependence	1.13e-05	0.000223	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOA—alcohol dependence	1.09e-05	0.000214	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—EP300—alcohol dependence	1.02e-05	0.000202	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EP300—alcohol dependence	9.9e-06	0.000195	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EP300—alcohol dependence	8.37e-06	0.000165	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—alcohol dependence	7.08e-06	0.00014	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—EP300—alcohol dependence	4.7e-06	9.26e-05	CbGpPWpGaD
